Immunohistochemical (IHC) analyses of human breast cancer samples reveal a high expression of p-STAT3 (Y705) and p-TrkA (Y490) in the tissue, supporting the co-activation of JAK2–STAT3 and TrkA pathways. The gene discussed is STAT3; the disease is breast cancer.